Published : Dec-2019
No. of Pages : 120
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Events: Malaysia Pharmaceutical News, 2010-2019
2.4 Key Events: Malaysian Pharmaceutical Market
2.5 Key Highlights: Healthcare Start-Ups in Malaysia
2.6 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Malaysia, 2018
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Product Launches
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Market - Supply Channels
3.6 Pharmaceutical Market - Market Segments
3.7 Medical Tourism, Malaysia
3.8 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments and Trade Partners
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Malaysia
7 HealthTech Landscape
7.1 HealthTech Deals Landscape, Malaysia
7.1.1 Key HealthTech Deals, Malaysia
7.2 Adoption of Technology in Healthcare, Malaysia
7.3 Key Developments: Technology in Healthcare, Malaysia
7.4 Regulatory Scenario Covering Use of Technology in Healthcare
7.5 HealthTech Landscape- Malaysia- Benefits and Risks
8 Pharmaceutical and Medical Device Market - Porter's Five Forces Analysis
8.1 Pharmaceutical Market, Malaysia - Porter's Five Forces Analysis
8.2 Medical Device Market, Malaysia - Porter's Five Forces Analysis
9 Market Access
9.1 Overview of Healthcare System, Malaysia
9.2 Reimbursement Process, Malaysia
9.2 Overview of Health Insurance, Malaysia
9.2.1 Healthcare Spending and Health Price Index, Malaysia
9.2.2 Pricing Policies, Malaysia
9.3 Regulatory Landscape, Malaysia
9.3.1 Market Authorization of Medical Products, Malaysia
9.3.2 Market Authorization of Medical Devices, Malaysia
9.3.3 Intellectual Property Rights, Patent, Malaysia
9.3.4 Intellectual Property Rights, Trademark, Malaysia
9.3.5 Clinical Trial Regulations, Malaysia
9.3.6 Pharmaceutical Clinical Trials Landscape, Malaysia
9.3.7 Medical Devices Clinical Trials Landscape, Malaysia
9.3.8 Clinical Trial Sites, Malaysia
9.3.9 Pharmaceutical Advertising Regulations, Malaysia
9.3.10 Pharmacy Regulations, Malaysia
9.3.11 Labeling and Packaging Regulations, Malaysia
10 Country Healthcare Landscape
11 Trade Associations, Malaysia
12 Trade Fairs, Malaysia
13 Opportunities and Challenges
14 Appendix
List of Tables
Table 1: Patent Fees, Malaysia, 2019
Table 2: Trademark Fees, Malaysia, 2019
Table 3: Trade Fairs
List of Figures
Figure 1: Pharmaceutical Market, Colombia, Revenue, 2011-2016
Figure 2: Pharmaceutical Market, Colombia, Revenue, 2017-2022
Figure 3: Healthcare Start-Ups in Colombia, 2019
Figure 4: Number of Deals (2017-2018)
Figure 5: 2017-2018 Deal Overview By Region
Figure 6: Country Profile, Colombia, 2018
Figure 7: Pharmaceutical Market, Colombia, Revenue, 2011-2016
Figure 8: Pharmaceutical Market, Colombia, Revenue Forecast, 2017-2022
Figure 9: Pharmaceutical Market, Colombia, Pharmaceutical Exports, 2018
Figure 10: Pharmaceutical Market, Colombia, Top Export Partners, 2018
Figure 11: Pharmaceutical Market, Colombia, Pharmaceutical Imports, 2018
Figure 12: Pharmaceutical Market, Colombia, Top Import Partners, 2018
Figure 13: Pharmaceutical Market, Pharmaceutical Supply Channel, Colombia, 2018
Figure 14: Pharmaceutical Market, OTC Market, Colombia, Revenue ($M), 2010-2018
Figure 15: Pharmaceutical Market, OTC Product Group Sales ($M), Colombia, 2018
Figure 16: Pharmaceutical Market, Colombia, Major Players
Figure 17:Deal Value and Deal Count, Pharmaceutical Market, Colombia, 2018-2019
Figure 18: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Colombia, 2018-2019
Figure 19: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Colombia, 2018-2019
Figure 20: Deal Value($M) , HealthTech, Colombia, 2018-2019
Figure 21: Deal Count, HealthTech, Colombia, 2018-2019
Figure 22: Adoption of Technology in Healthcare, Colombia, 2019
Figure 23: Market Access, Overview of Healthcare System, Colombia, 2019
Figure 24: Market Access, OOP Expenditure (% of Total Expenditure on Health), Colombia
Figure 25: Market Access, Annual Average Rates of Price Change (%), Consumer Price Index, Colombia, 2014-2018
Figure 26: Market Access, SISMED Monitoring Process, Colombia, 2018
Figure 27: Market Access, Structure of INVIMA, Colombia, 2018
Figure 28: Market Access, Registration Process for New Drugs, 2019
Figure 29: Market Access, Regulatory Landscape, Generic Drug Approval Process, Colombia, 2018
Figure 30: Medical Device (Class I, IIa, IIb, III) Registration Requirements, Colombia
Figure 31: Medical Device (Class I, IIa, IIb, III) Registration Requirements, Colombia
Figure 32: Licensing Process for Manufacturing, Colombia, 2018
Figure 33: Patent Approval Process, Colombia, 2018
Figure 34: Pharmaceutical Clinical Trials Count By Trial Status, Colombia, 2018-2019
Figure 35: Pharmaceutical Clinical Trials Count By Phase, Colombia, 2018-2019
Figure 36: Pharmaceutical Clinical Trials Count By Therapy Area, Colombia, 2018-2019
Figure 37: Pharmaceutical Clinical Trials Site, Colombia, 2018-2019
Figure 38: Colombia Healthcare Policy Highlights, Colombia, 2019
Figure 39: Hospital Beds (per 1,000 Population), Colombia, 2010-2018
Figure 40: Diagnostic Equipment (per million population), Colombia, 2011-2018
Figure 41: Life Expectancy, 2010-2018, Colombia
Figure 42: Immunization Rate (%), 2010-2018, Colombia
Figure 43: PM2.5 (µg per m3), Colombia, 2010-2018
Figure 44: CO2 Emissions (Million Tons), Colombia, 2010-2018
Figure 45: Physicians (per 1,000 Population), Colombia, 2011-2018
Figure 46: Nurses (per 1,000 Population), Colombia, 2011-2018
Figure 47: Dentists (per 1,000 Population), Colombia, 2011-2018
Figure 48: Major Causes of Mortality (per 1,000 Population), Colombia, 2016
Figure 49: Major Causes of Male Mortality, Colombia, 2016
Figure 50: Major Causes of Female Mortality, Colombia, 2016
Figure 51: Disability-Adjusted Life Years by Major Disease (000), Colombia, 2016
Figure 52: Healthcare Expenditure as Percentage of GDP (%), Colombia, 2011-2018
Figure 53: Public-Private Share (%), Colombia, 2011-2018
Figure 54: Opportunities and Challenges, Colombia
